Trials / Completed
CompletedNCT01413542
Pharmacogenetics of Ace Inhibitor-Associated Angioedema
Pharmacogenetics of Ace Inhibitor-Associated Angioedema:Aim 1
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 44 (actual)
- Sponsor
- Vanderbilt University · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The investigators would like to find out if sitagliptin (dipeptidyl peptidase-4 or DPP4 inhibition), a drug to treat diabetes, affects blood vessel relaxation in healthy people receiving enalapril (angiotensin converting enzyme or ACE inhibition), a blood pressure medicine. Understanding how these drugs interact in healthy people will help us learn their potential effects in people who have diabetes.
Detailed description
To test the hypothesis that DPPIV inhibition with sitagliptin potentiates the vasodilator response to substance P in the presence of ACE inhibition with enalaprilat and to BNP and GLP-1 even in the presence of ACE inhibition. The aim promises to provide important new data regarding the mechanism of action of DPPIV inhibitors and interactive effects of these two drug classes used in a growing population of diabetic patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sitagliptin (DPP4 inhibitor) | Sitagliptin 200 mg (DPP4 inhibitor) or matching placebo will be given one hour prior to intra-arterial infusions |
| DRUG | Substance P, | Substance P intra-brachial artery (2,4,8 pmol/min) |
| DRUG | bradykinin | bradykinin intra-brachial artery (23.6, 47.2, and 94.3 pmol/min) |
| DRUG | enalaprilat (ACE inhibitor) | intra-brachial artery(0.33 µg/min per 100 mL forearm volume) |
| DRUG | Glucagon-like peptide 1 | intra-brachial artery (0.45-3.60 pmol/min) |
| DRUG | brain natriuretic peptide | Intra-brachial artery (0.90, 1.80 and 3.6 pmol/min) |
Timeline
- Start date
- 2011-11-01
- Primary completion
- 2013-07-01
- Completion
- 2014-07-01
- First posted
- 2011-08-10
- Last updated
- 2015-11-04
- Results posted
- 2015-11-04
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01413542. Inclusion in this directory is not an endorsement.